BIOSYNEX: Declaration of the number of shares and voting rights

BIOSYNEX SA recently published data relating to its share capital and voting rights as of February 28, 2025. According to the announcement made on March 4, 2025, the total number of shares in the company amounts to 18,748,031. As of the same date, the total net voting rights reached 22,531,235.

This publication is part of the legal obligations established by Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Financial Markets Authority. Belonging to the health diagnostics sector, BIOSYNEX offers innovative solutions designed to improve the patient care pathway, collaborating with various medical structures and the general public.